Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Affinia Therapeutics logo

Affinia Therapeutics

Recent Finacing

Series C

Recent Raise

$40M

Affinia Therapeutics is a gene therapy company developing first- or best-in-class AAV medicines for severe cardiovascular and neurological diseases.

Massachusetts, United States
51-100
Private
affiniatx.com
PitchBook

Highlights

Focus Areas

Biotechnology
Health Care
Life Science
Therapeutics

Recent Investors

New Enterprise Associates logo
Atlas Venture logo
F-Prime Capital logo
Avidity Partners logo
Perceptive Advisors logo
Mass General Brigham Ventures logo
Lonza logo
Google Ventures logo
Alexandria Venture Investments logo
TCGX logo
Farallon Capital Management logo
O

Financials

$210M

Total Raised

3

Funding rounds

18

Investors


Team

Upgrade to view the team

See the team members at Affinia Therapeutics.